Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity ...

At the Healthcare Analytics Summit™ 2024 (HAS® 24), Jennifer Doudna, PhD, of the University of California, Berkeley, sat down with Melissa Welch, MD, MPH, President of Welch Perspectives Healthcare ...

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara co-present Dr. Jennifer Doudna, CRISPR Gene Editing and the Future of Human Health on Tuesday, Oct. 22, at 7:30 p.m. at The Granada ...

Nicole and Kyle Muldoon with their child, KJ, who received a CRISPR gene editing therapy at Children's Hospital of Philadelphia. From the San Francisco Business Times. Months after helping manufacture ...

Nobel Prize–winning biochemist Dr. Jennifer Doudna is cracking the code of nature to address big issues, using the tiniest parts of us. On Tuesday, UCSB Arts & Lectures and the Cancer Foundation of ...

You’re reading Book Currents, a weekly column in which notable figures share what they’re reading. Sign up for the Goings On newsletter to receive their selections, and other cultural recommendations, ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth. To date, there haven’t been many reliable ...

In honor of Women’s History Month, Big Molecule Watch recognizes Emmanuelle Charpentier and Jennifer Doudna, who won the Nobel Prize for a method for genome editing, commonly called CRISPR or ...

This content was paid for by an advertiser and created by The Daily Tar Heel's marketing agency. The Daily Tar Heel newsroom was not involved in creating this content. As the Oliver Smithies Nobel ...

BERKELEY, Calif. (KGO) -- UC Berkeley Professor Jennifer Doudna won the Nobel Prize in Chemistry Wednesday morning along with French Microbiologist Emmanuelle Charpentier for their work on genome ...

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. Now, a ...